Show
Sort by
-
Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature
-
- Journal Article
- A1
- open access
Response to : 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial' by Cai and Peng response
-
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2) : a randomised, double-blind, placebo-controlled, phase 3 trial
-
Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis
-
- Journal Article
- A1
- open access
Upadacitinib in active ankylosing spondylitis : results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension